The United States Pharmacopeia (USP) has announced its support for collaboration among pharmacist organizations in creating a voluntary pharmacy accreditation program for compounding. The Pharmacy Compounding Accreditation Board was established to help enhance the quality and raise awareness about compounding.
A coalition of pharmacy-related professional, regulatory, and standards-setting organizations initiated the program. "We are excited about being a member of this new board," said Roger L. Williams, MD, executive vice president and chief executive officer at USP. "By working together, we will improve the quality of pharmacy compounding in the United States, which ultimately improves patient care throughout the nation."
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs